|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001779,
umls-concept:C0018270,
umls-concept:C0021294,
umls-concept:C0023779,
umls-concept:C0032105,
umls-concept:C0032615,
umls-concept:C0220825,
umls-concept:C0439230,
umls-concept:C0489829,
umls-concept:C0547043,
umls-concept:C0728731,
umls-concept:C1704410,
umls-concept:C1705501,
umls-concept:C2348609
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1999-10-4
|
|
pubmed:abstractText |
The last trimester of pregnancy is a period of rapid accretion of long-chain polyunsaturated fatty acids, both in the central nervous system and the body as a whole. Human milk contains these fatty acids, whereas some preterm infant formulas do not. Infants fed formulas without these fatty acids have lower plasma and erythrocyte concentrations than infants fed human milk. Preclinical and clinical studies have demonstrated that single-cell sources (algal and fungal) of long-chain polyunsaturated fatty acids are bioavailable. A balanced addition of fatty acids from these oils to preterm formula results in blood fatty acid concentrations in low birth weight infants comparable to those of infants fed human milk.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0277-2116
|
|
pubmed:author |
pubmed-author:AdamkinDD,
pubmed-author:BreamP RPR,
pubmed-author:ChanGG,
pubmed-author:ClandininTT,
pubmed-author:CowettRR,
pubmed-author:DeCristofaroJJ,
pubmed-author:EulerAA,
pubmed-author:GrossSS,
pubmed-author:HegyiTT,
pubmed-author:HeirdWW,
pubmed-author:Hook-MorrisBB,
pubmed-author:LienE LEL,
pubmed-author:McCartonCC,
pubmed-author:PereiraGG,
pubmed-author:PorcelliPP,
pubmed-author:PramukKK,
pubmed-author:RhodesTT,
pubmed-author:ShattuckKK,
pubmed-author:TsangRR,
pubmed-author:Van AerdeJJ,
pubmed-author:VanderhoofJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
318-26
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10467999-Aging,
pubmed-meshheading:10467999-Anthropometry,
pubmed-meshheading:10467999-Double-Blind Method,
pubmed-meshheading:10467999-Fatty Acids, Unsaturated,
pubmed-meshheading:10467999-Humans,
pubmed-meshheading:10467999-Infant, Newborn,
pubmed-meshheading:10467999-Infant, Premature,
pubmed-meshheading:10467999-Infant Food,
pubmed-meshheading:10467999-Lipids,
pubmed-meshheading:10467999-Milk, Human,
pubmed-meshheading:10467999-Prospective Studies,
pubmed-meshheading:10467999-Weight Gain
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Evaluation of a long-chain polyunsaturated fatty acid supplemented formula on growth, tolerance, and plasma lipids in preterm infants up to 48 weeks postconceptional age.
|
|
pubmed:affiliation |
University of Nebraska Medical Center, Omaha, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
